Details

Autor(en) / Beteiligte

• Aggarwal, Savera
• Yadav, Vipin
• Maiwall, Rakhi
• Rastogi, Archana
• Pamecha, Viniyendra
• Bedi, Onkar
• Maras, Jaswinder Singh
• Trehanpati, Nirupma
• Ramakrishna, Gayatri

Titel

Metabolomic analysis shows dysregulation in amino acid and NAD+ metabolism in palmitate treated hepatocytes and plasma of non-alcoholic fatty liver disease spectrum

Ist Teil von

• Biochemical and biophysical research communications, 2023-02, Vol.643, p.129-138

Ort / Verlag

United States: Elsevier Inc

Erscheinungsjahr

2023

Quelle

Access via ScienceDirect (Elsevier)

Beschreibungen/Notizen

• There is an alarming increase in incidence of fatty liver disease worldwide. The fatty liver disease spectrum disease ranges from simple steatosis (NAFL) to steatohepatitis (NASH) which culminates in cirrhosis and cancer. Altered metabolism is a hallmark feature associated with fatty liver disease and palmitic acid is the most abundant saturated fatty acid, therefore, the aim of this study was to compare metabolic profiles altered in hepatocytes treated with palmitic acid and also the differentially expressed plasma metabolites in spectrum of nonalcoholic fatty liver. The metabolites were analyzed by liquid chromatography-mass spectrometry (LC-MS) platform. Hepatocyte cell lines PH5CH8 and HepG2 cells when treated with 400 μM dose of palmitic acid showed typical features of steatosis. Metabolomic analysis of lipid treated hepatocyte cell lines showed differential changes in phenylalanine and tyrosine pathways, fatty acid metabolism and bile acids. The key metabolites tryptophan, kynurenine and carnitine differed significantly between subjects with NAFL, NASH and those with cirrhosis. As the tryptophan-kynurenine axis is also involved in denovo synthesis of NAD+, we found significant alterations in the NAD+ related metabolites in both palmitic acid treated and also fatty liver disease with cirrhosis. The study underscores the importance of amino acid and NAD+supplementation as promising strategies in fatty liver disorder. •Palmitic acid treatement pertubs phenylalanine and tyrosine pathways in addition to fatty acid metabolism .•Tryptophan-kynurenine axis appeared deregulated in subjects with NASH-associated cirrhosis.•Altered levels of NAD+ and its related metabolites in progression of fatty liver disease.